Rapid relief from inflammation and pruritus
Cortavance® is a potent topical steroid, containing HCA, for the symptomatic treatment of inflammatory and pruritic skin disorders
Product features & benefits:
Use medicines responsibly. www.noah.co.uk/responsible.
Further information is available on the SPC or on request from Virbac Ltd.
1. Olivry T, DeBoer DJ, Favrot C, et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.Vet Dermatol. 2010;21(3):233–248.
Antimicrobial Peptides: The What, The How and The Why
Antimicrobial resistance is a hot topic in both human and veterinary medicine, with concerns flagged that inappropriate use of antibiotics may have contributed to an increase in bacterial resistance worldwide.
Do Sugars Have Any Role in Dermatology Today?
Sugars, or carbohydrates, are the most abundant class of organic compounds found in living organisms. There are two major subfamilies; the simple sugars (monosaccharides) and the complex sugars (oligosaccharides composed of 2-10 monosaccharides and polysaccharides composed of more than 10 monosaccharides).
Cortavance spray is a topically applied veterinary medicine used to treat inflamed and itchy skin conditions in dogs and for alleviation of clinical signs associated with atopic dermatitis in dogs. It contains the active substance hydrocortisone aceponate, a locally active potent glucocorticoid.
Two pump spray activations over a surface to be treated equivalent to a square of 10 cm x 10 cm. Repeat the treatment daily for 7 consecutive days.
HCA spray has a good safety profile. There were no changes to haematology, biochemistry, adrenal function or skin thickness in safety studies where up to 1/3 of the body surface area of healthy dogs was treated daily for up to eight weeks. In addition, no adverse effects or altered haematology, biochemistry and ACTH stimulation tests were seen in dogs treated in clinical trials for up to 70 days. One recent study, however, noted some thinning of the abdominal skin, so careful monitoring of dogs treated in this area is advised.
The product should be used within 6 months after opening and before the date of expiry.
Although the safety of the veterinary medicinal product has not been established during pregnancy and lactation the systemic absorption of hydrocortisone aceponate is negligible and it is unlikely to be teratogenic, foetotoxic or maternotoxic at the recommended dosage in dogs. Use only accordingly to the risk-benefit assessment by the responsible veterinarian.
As there is negligible systemic absorption at the label dose rates the risk of interaction is minimal. It is recommended that other topical medicines are not applied at the same site as the Cortavance treatment area.